Yesintek™ (ustekinumab-kfce)
for Arthritis Psoriatic

Yesintek (ustekinumab-kfce), an interleukin inhibitor, is a biosimilar to Stelara that blocks IL-12 and IL-23 to reduce inflammation. It treats moderate to severe plaque psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis in adults.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Arthritis Psoriatic